Development and evaluation of intestinal targeted mucoadhesive microspheres of Bacillus coagulans

Drug Development and Industrial Pharmacy

Volumn 37, Issue 11, 2011, Pages 1329-1338

  Alli, Sk Md Athar ^a   Ali, Sk Md Ajhar ^b   Samanta, Amalesh ^a  

^a JADAVPUR UNIVERSITY   (India)

^b UTKAL UNIVERSITY   (India)

Author keywords

Bacillus coagulans; Extended release; Microspheres; Mucoadhesive; Probiotics

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; MICROSPHERE; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS COAGULANS; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; EX VIVO STUDY; FEMALE; FREEZE DRYING; IN VITRO STUDY; INTESTINE MUCOSA; MALE; MORPHOLOGY; MUCOADHESION; NONHUMAN; PARTICLE SIZE; POWDER; PROTECTION; RAT; ROOM TEMPERATURE; SCANNING ELECTRON MICROSCOPY; SEPARATION TECHNIQUE; STOMACH; STOMACH PH; STRENGTH; SURFACE PROPERTY;

ADHESIVENESS; ANALYSIS OF VARIANCE; ANIMALS; BACILLUS; DELAYED-ACTION PREPARATIONS; HUMANS; INTESTINAL MUCOSA; MICE; MICROSPHERES; MODELS, BIOLOGICAL; MUCUS; PARTICLE SIZE; PROBIOTICS;

EID: 80053940462     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.572889     Document Type: Article

References (30)

1. Mitsuoka T. (1992). Role of intestinal flora in health with special reference to dietary control of intestinal flora. In: Hga BH, Lee YK, eds. Microbiology Applications in Food Biotechnology. London: Elsevier Science Publishers Ltd., pp. 135-148.
2. Kim HS, Gilliland SE. (1983). Lactobacillus acidophilus as a dietary adjunct for milk to aid lactose digestion in humans. J Dairy Sci, 66:959-966.
3. Kirjavainen PV, Apostolou E, Salminen SJ, Isolauri E. (1999). New aspects of probiotics-a novel approach in the management of food allergy. Allergy, 54:909-915. (Pubitemid 29434262)
4. Orrhage K, Nord CE. (2000). Bifidobacteria and lactobacilli in human health. Drugs Exp Clin Res, 26:95-111. (Pubitemid 30479604)
5. Sanders ME, Morelli L, Tompkins TA. (2003). Spore formers as human probiotics: Bacillus, Sporolactobacillus, and Brevibacillus. Comp Rev Food Sci Food Saf, 2:101-110.
6. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, Reddy BS. (1997). Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis, 18:833-841. (Pubitemid 28132475)
7. Krasaekoopt W, Bhandari B, Deeth H. (2003). Evaluation of encapsulation techniques of probiotics for yoghurt. Int Dairy J, 13:3-13. (Pubitemid 36238329)
8. Chandramouli V, Kailasapathy K, Peiris P, Jones M. (2004). An improved method of microencapsulation and its evaluation to protect Lactobacillus spp. in simulated gastric conditions. J Microbiol Methods, 56:27-35. (Pubitemid 38045443)
9. Gilliand SE, Speck ML. (1977). Instability of Lactobacillus acidophilus in yogurt. J Dairy Sci, 60:1394-1398.
10. Lankaputhra WEV, Shah NP. (1995). Survival of Lactobacillus acidophilus and Bifidobacterium spp. in the presence of acid and bile salts. Cult Dairy Prod J, 30:2-7.
11. O'Riordan K, Andrews D, Buckle K, Conway P. (2001). Evaluation of microencapsulation of a Bifidobacterium strain with starch as an approach to prolonging viability during storage. J Appl Microbiol, 91:1059-1066. (Pubitemid 33132074)
12. Shah NP. (2000). Probiotic bacteria: selective enumeration and survival in dairy foods. J Dairy Sci, 83:894-907.
13. Sultana K, Godward G, Reynolds N, Arumugaswamy R, Peiris P, Kailasapathy K. (2000). Encapsulation of probiotic bacteria with alginate-starch and evaluation of survival in simulated gastrointestinal conditions and in yoghurt. Int J Food Microbiol, 62:47-55.
14. Asane GS, Nirmal SA, Rasal KB, Naik AA, Mahadik MS, Rao YM. (2008). Polymers for mucoadhesive drug delivery system: a current status. Drug Dev Ind Pharm, 34:1246-1266.
15. Belgamwar V, Shah V, Surana SJ. (2009). Formulation and evaluation of oral mucoadhesive multiparticulate system containing metoprolol tartarate: an in vitro-ex vivo characterization. Curr Drug Deliv, 6:113-121.
16. Chowdary KP, Rao YS. (2004). Mucoadhesive microspheres for controlled drug delivery. Biol Pharm Bull, 27:1717-1724. (Pubitemid 41701593)
17. Bora PS, Puri V, Bansal AK. (2009). Physicochemical properties and excipient compatibility studies of probiotic Bacillus coagulans spores. Sci Pharm, 77:625-637.
18. Li CL, Martini LG, Ford JL, Roberts M. (2005). The use of hypromellose in oral drug delivery. J Pharm Pharmacol, 57:533-546. (Pubitemid 40562392)
19. Rowe RC, Sheskey PJ, Owen SC, eds. (2006). Handbook of Pharmaceutical Excipients, 5th ed. Britain: Great Pharmaceutical Press and Washington DC: American Pharmacists Association, pp. 346-358.
20. Zhang L, Liu Y, Wu Z, Chen H. (2009). Preparation and characterization of coacervate microcapsules for the delivery of antimicrobial oyster peptides. Drug Dev Ind Pharm, 35:369-378.
21. United States Pharmacopoeial Convention (USPC). (2007). United States Pharmacopoeia-National Formulary (USP-NF) 2008. Rockville, MD: US Pharmacopoeial Convention, Inc., pp. 639-641, 814, 820.
22. Shakoori AR, Anwar S, Khurshed N, Riaz-ul-Haq. (1999). Biocidal activity of Bacillus species for Anopheles larvae. Folia Biol (Krakow), 47:143-148. (Pubitemid 30048694)
23. Yassin AE, Alanazi FK, El-Badry M, Alsarra IA, Barakat NS, Alanazi FK. (2009). Preparation and characterization of spironolactoneloaded gelucire microparticles using spray-drying technique. Drug Dev Ind Pharm, 35:297-304.
24. Fan Y, Shan-Guang W, Yu-Fang P, Feng-Lan S, Tao L. (2009). Preparation and characteristics of erythromycin microspheres for lung targeting. Drug Dev Ind Pharm, 35:639-645.
25. Nagda C, Chotai NP, Patel U, Patel S, Soni T, Patel P et al. (2009). Preparation and characterization of spray-dried mucoadhesive microspheres of aceclofenac. Drug Dev Ind Pharm, 35:1155-1166.
26. Lehr CM, Bowstra JA, Tukker JJ, Junginer HE. (1990). Intestinal transit of bioadhesive microspheres in an in-situ loop in the rat. J Control Release, 13:51-62.
27. Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123-133. (Pubitemid 32288781)
28. Soni T, Chotai N. (2010). Assessment of dissolution profile of marketed aceclofenac formulations. J Young Pharm, 2:21-26.
29. Donskey CJ, Hoyen CK, Das SM, Farmer S, Dery M, Bonomo RA. (2001). Effect of oral Bacillus coagulans administration on the density of vancomycin-resistant enterococci in the stool of colonized mice. Lett Appl Microbiol, 33:84-88. (Pubitemid 32625739)
30. Chi N, Tang X, Xu H. (2009). Development and optimization of chemically stable lipid microspheres containing flunarizine. Drug Dev Ind Pharm, 35:738-745.